Nanochon, INC (“Nanochon” or the “Company”) is developing and commercializing a implantable medical device. This disruptive technology is targeted to treat knee injuries in younger and more active patients. Younger and more active patients are usually under 55 years old and need/want to return to work, sports, and other strenuous physical activities. Nanochon will be a “gold standard” for patients wanting to return to an active life.